Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Institute of Ophthalmology

Home
Menu

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø spinout tackling eye disease announces £57m launch

12 July 2023

Tenpoint Therapeutics, which spun out of Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø in 2021, has announced its launch to address degenerative eye diseases.

istock

The biotechnology company uses pioneering cell engineering to replace damaged cells in the eye to tackle age-related or inherited sight loss. The technology could potentially restore sight to millions affected.

The experts at Tenpoint Therapeutics, from the Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Institute of Ophthalmology, Moorfields Eye Hospital, Institut de la Vision in Paris and the University of Washington in the US, are the first to combine different types of cell-based therapeutics and enable treatments that are tailored to the nature of individual cases, replacing cells in the eye that have been damaged by age-related or inherited disease.